Literature DB >> 30625401

Tofacitinib: A Jak of All Trades.

Kristin E Burke1, Ashwin N Ananthakrishnan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30625401      PMCID： PMC6588476          DOI： 10.1016/j.cgh.2018.12.044

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  20 in total

Review 1.  Systematic Review: Sequential Rescue Therapy in Severe Ulcerative Colitis: Do the Benefits Outweigh the Risks?

Authors:  Neeraj Narula; Michael Fine; Jean-Frederic Colombel; John K Marshall; Walter Reinisch
Journal:  Inflamm Bowel Dis       Date:  2015-07       Impact factor: 5.325

2.  Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review.

Authors:  Mathurin Fumery; Siddharth Singh; Parambir S Dulai; Corinne Gower-Rousseau; Laurent Peyrin-Biroulet; William J Sandborn
Journal:  Clin Gastroenterol Hepatol       Date:  2017-06-16       Impact factor: 11.382

3.  Heterogeneity in Definitions of Endpoints for Clinical Trials of Ulcerative Colitis: A Systematic Review for Development of a Core Outcome Set.

Authors:  Christopher Ma; Remo Panaccione; Richard N Fedorak; Claire E Parker; Tran M Nguyen; Reena Khanna; Corey A Siegel; Laurent Peyrin-Biroulet; Geert D'Haens; William J Sandborn; Brian G Feagan; Vipul Jairath
Journal:  Clin Gastroenterol Hepatol       Date:  2017-08-24       Impact factor: 11.382

4.  Overall and Comparative Risk of Herpes Zoster With Pharmacotherapy for Inflammatory Bowel Diseases: A Nationwide Cohort Study.

Authors:  Nabeel Khan; Dhruvan Patel; Chinmay Trivedi; Yash Shah; Gary Lichtenstein; James Lewis; Yu-Xiao Yang
Journal:  Clin Gastroenterol Hepatol       Date:  2018-01-05       Impact factor: 11.382

5.  Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.

Authors:  William J Sandborn; Chinyu Su; Bruce E Sands; Geert R D'Haens; Séverine Vermeire; Stefan Schreiber; Silvio Danese; Brian G Feagan; Walter Reinisch; Wojciech Niezychowski; Gary Friedman; Nervin Lawendy; Dahong Yu; Deborah Woodworth; Arnab Mukherjee; Haiying Zhang; Paul Healey; Julian Panés
Journal:  N Engl J Med       Date:  2017-05-04       Impact factor: 91.245

6.  Prevalence of Inflammatory Bowel Disease Among Adults Aged ≥18 Years - United States, 2015.

Authors:  James M Dahlhamer; Emily P Zammitti; Brian W Ward; Anne G Wheaton; Janet B Croft
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-10-28       Impact factor: 17.586

7.  Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease.

Authors:  Gauree Gupta; Ebbing Lautenbach; James D Lewis
Journal:  Clin Gastroenterol Hepatol       Date:  2006-12       Impact factor: 11.382

8.  Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults.

Authors:  Himal Lal; Anthony L Cunningham; Olivier Godeaux; Roman Chlibek; Javier Diez-Domingo; Shinn-Jang Hwang; Myron J Levin; Janet E McElhaney; Airi Poder; Joan Puig-Barberà; Timo Vesikari; Daisuke Watanabe; Lily Weckx; Toufik Zahaf; Thomas C Heineman
Journal:  N Engl J Med       Date:  2015-04-28       Impact factor: 91.245

9.  Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease.

Authors:  M D Long; C Martin; R S Sandler; M D Kappelman
Journal:  Aliment Pharmacol Ther       Date:  2012-12-13       Impact factor: 8.171

10.  Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy.

Authors:  Kevin L Winthrop; Jeffrey R Curtis; Stephen Lindsey; Yoshiya Tanaka; Kunihiro Yamaoka; Hernan Valdez; Tomohiro Hirose; Chudy I Nduaka; Lisy Wang; Alan M Mendelsohn; Haiyun Fan; Connie Chen; Eustratios Bananis
Journal:  Arthritis Rheumatol       Date:  2017-09-06       Impact factor: 10.995
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.